Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori
- 1 May 2015
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 486 (1-2) , 297-305
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mucoadhesive and muco-penetrating delivery systems for eradication of helicobacter pyloriAsian Journal of Pharmaceutics, 2012
- Helicobacter pylori: a poor man's gut pathogen?Gut Pathogens, 2010
- Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pyloriJournal of Controlled Release, 2008
- Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matricesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pyloriInternational Journal of Pharmaceutics, 2007
- New Insights into the Mechanism of Gelation of Alginate and Pectin: Charge Annihilation and Reversal MechanismBiomacromolecules, 2005
- Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulationsInternational Journal of Pharmaceutics, 2003
- Cubic phase gels as drug delivery systemsAdvanced Drug Delivery Reviews, 2001
- Gelling Properties of Gellan Solutions Containing Monovalent and Divalent CationsJournal of Food Science, 1997
- Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timololInternational Journal of Pharmaceutics, 1989